Statement Of Cash Flows

Kidswell Bio Corporation - Filing #7709243

Concept As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
As at
2017-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-854,391,000 JPY
-902,657,000 JPY
Depreciation
716,000 JPY
313,000 JPY
Interest and dividend income
-121,000 JPY
-157,000 JPY
Increase (decrease) in provision for retirement benefits
4,530,000 JPY
-180,000 JPY
Decrease (increase) in trade receivables
-154,310,000 JPY
182,429,000 JPY
Decrease (increase) in inventories
-11,932,000 JPY
JPY
Subtotal
-858,537,000 JPY
-436,110,000 JPY
Increase (decrease) in trade payables
-3,390,000 JPY
60,134,000 JPY
Income taxes paid
-1,900,000 JPY
-2,420,000 JPY
Other, net
13,947,000 JPY
20,858,000 JPY
Net cash provided by (used in) operating activities
-860,316,000 JPY
-438,372,000 JPY
Interest and dividends received
121,000 JPY
157,000 JPY
Cash flows from operating activities
Increase (decrease) in accounts payable - other
-23,226,000 JPY
179,774,000 JPY
Cash flows from operating activities
Cash flows from facilities maintenance and investing activities
Purchase of property, plant and equipment
JPY
-252,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
-27,000 JPY
-50,252,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
978,446,000 JPY
JPY
Net increase (decrease) in cash and cash equivalents
118,102,000 JPY
-488,625,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Cash and cash equivalents
2,009,373,000 JPY
1,891,271,000 JPY
2,379,896,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.